196 related articles for article (PubMed ID: 17441477)
1. [Complications in the central nervous system during chemotherapy for childhood acute lymphoblastic leukemia: JACLS ALL-02 study].
Umeda K; Yoshida M; Suzuki N; Endo M; Sato A; Hori H; Isogai M; Matsumoto K; Hara JI; Hasegawa D; Hashii Y; Chayama K; Miyaji R; Nishimura S; Tanizawa A; Uami I; Horibe K; Wakazono Y; Yagi K
Rinsho Ketsueki; 2007 Mar; 48(3):204-11. PubMed ID: 17441477
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
3. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
4. Is high dose methotrexate without irradiation of the brain sufficiently effective in prevention of CNS disease in children with acute lymphoblastic leukemia?
Cáp J; Foltinová A; Kaiserová E; Mojzesová A; Sejnová D; Jamárik M
Neoplasma; 1998; 45(3):176-9. PubMed ID: 9717531
[TBL] [Abstract][Full Text] [Related]
5. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
7. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
8. Moyamoya syndrome following childhood acute lymphoblastic leukemia.
Kikuchi A; Maeda M; Hanada R; Okimoto Y; Ishimoto K; Kaneko T; Ikuta K; Tsuchida M;
Pediatr Blood Cancer; 2007 Mar; 48(3):268-72. PubMed ID: 16615044
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
[TBL] [Abstract][Full Text] [Related]
10. [A case report of childhood acute lymphoblastic leukemia with leukoencephalopathy that responded to oxygenation under hyperbaric pressure therapy].
Kanekura S; Takezaki T; Kawakami K
Rinsho Ketsueki; 1992 Sep; 33(9):1221-5. PubMed ID: 1433944
[TBL] [Abstract][Full Text] [Related]
11. [Neurologic complications during chemotherapy of children with acute lymphoid leukemia].
Kardos M; Grexa E; Kajtár P
Orv Hetil; 1992 May; 133(18):1111-5. PubMed ID: 1579351
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
Parasole R; Petruzziello F; Menna G; Mangione A; Cianciulli E; Buffardi S; Marchese L; Nastro A; Misuraca A; Poggi V
Leuk Lymphoma; 2010 Jun; 51(6):1063-71. PubMed ID: 20470218
[TBL] [Abstract][Full Text] [Related]
13. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia.
Aytaç S; Yetgin S; Tavil B
Turk J Pediatr; 2006; 48(1):1-7. PubMed ID: 16562778
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
[TBL] [Abstract][Full Text] [Related]
15. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
16. [Childhood acute lymphoblastic leukemia in Norway 1992-2000].
Kolmannskog S; Flaegstad T; Helgestad J; Hellebostad M; Zeller B; Glomstein A
Tidsskr Nor Laegeforen; 2007 May; 127(11):1493-5. PubMed ID: 17551551
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
Buizer AI; de Sonneville LM; van den Heuvel-Eibrink MM; Veerman AJ
Pediatr Blood Cancer; 2005 Sep; 45(3):281-90. PubMed ID: 15806539
[TBL] [Abstract][Full Text] [Related]
18. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system lymphoma in children.
Porto L; Kieslich M; Schwabe D; Yan B; Zanella FE; Lanfermann H
Pediatr Hematol Oncol; 2005; 22(3):235-46. PubMed ID: 16020108
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]